Plunkett Research Online: Sangamo Therapeutics Inc

SANGAMO THERAPEUTICS INC (SGMO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies. The company accomplishes this through its platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo engages in the rese.....



Sangamo Therapeutics Inc
Ticker: SGMO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510 970-6000
Fax: 510 236-8951
Address: 501 Canal Boulevard
Richmond, CA 94804 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Research & Development
Gene Expression Regulation Therapies
Transcription Factor Technology
ContactsDescription
Alexander MacraeCEO/President/Director
Kathy YiCFO/Chief Accounting Officer/Senior VP
See More
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies. The company accomplishes this through its platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo engages in the rese.....See More See More

Auditor: ERNST & YOUNG, LLP
Legal Advisor: Morgan, Lewis & Bockius LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
SB-525
SB-FIX
SB-318
SB-913
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: